Formulation and evaluation of piroxicam liquisolid compacts

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 1, 2013, Pages 132-141

  Jabbar, Ahmed S Abdul ^a   Hussein, Ahmed A ^b  

^a UNIVERSITY OF BASRAH   (Iraq)

^b UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Dissolution rate; Liquisolid compacts; PEG 400; Piroxicam

Indexed keywords

CROSCARMELLOSE SODIUM; MICROCRYSTALLINE CELLULOSE; PIROXICAM;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; LIQUISOLID COMPACT; MATHEMATICAL MODEL; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY POWDER DIFFRACTION;

EID: 84874507594     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Spireas S, Bolton M. Liquisolid Systems and Methods of Preparing Same. U. S Patent 5, 968, 550, 1999.
2. Spireas S. Liquisolid Systems and Methods of Preparing Same. U. S Patent 6, 423, 339 B1, 2002.
3. Sheth A, Jarowski C. I. Use of powdered solutions to improve the dissolution rate of polythiazide tablets. Int. J. Pharm. 1990; 16 (5): 769-777.
4. Spireas S, Wang T., Grover R. Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts. Drug Dev. Ind. Pharm. 1999; 25 (2): 163-168.
5. Nokhodchi A. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharma. Sci. 2005; 8 (1): 18-25.
6. Javadzadeh Y, Siahi-Shadbad M. R., Barzegar-Jalali M., Nokhodchi A. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Il armaco. 2005; 60: 361-365.
7. Spireas S, Sadu S, Grover R. In-vitro release evaluation of hydrocortisone liquisolid tablets. J. Pharm. Sci. 1998; 87 (7): 867-872.
8. Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int. J. Pharm. 1998; 166: 177-188.
9. Nelson E. Physicochemical and pharmaceutics properties of drugs that influence the results of clinical trials. Clin. Pharmacol. Ther. 1962; 3: 673-681.
10. Amidon G. L, Lennernas H., Crison J. R. A theoretical basis for biopharmaceutics drugs classification: the correlation of in vitro drug product dissolution and in-vivo bioavailability. Pharm. Res. 1999; 12: 413-420.
11. Abdou H. M, In: Abdou H. M. (Ed.). Dissolution, bioavailability and bioequivalence. Easton, Mack Pub. Co., PA. 1989: 53-72
12. Staniforth J, In: Aulton M. (Ed.). Pharmaceutics: the science of dosage form design. Edinburgh: Churchill Livingstone, Longman group. 2002: 197-210
13. rd ed. Informa Healthcare USA Inc. 2007; 3: 3707-3716
14. British Pharmacopoeia. Appendix XII A. Disintegration Test for Tablets and Capsules. 2009; 1-2
15. Ravikiran N. Design and evaluation of Orodispersible tablet of Piroxicam using different Superdisintegrants International Journal of Drug Formulation & Research. 2010: 349-374.
16. El-Gizawy SA. Effect of formulation additives in the dissolution of Meloxicam from Liquid solid tablets. Egypt J Biomed Sci. 2007; 25: 143-158.
17. Rajendarn A. and Basu S. K. Crystal modification of dipyridamole using different solvents and crystallization conditions. Int. J. Pharm. 2006; 321: 27-34
18. Spireas S, Jarowski C. I., Rohera B. D. Powdered solution technology: principles and mechanism Pharm. Res. 1992; 9 (10): 1351-1358.
19. Rowe R. C, Sheskey P. J., Weller P. J. Handbook of Pharmaceutical Excipients, fourth ed., American Pharmaceutical Association, Chicago 2003: pp. 108-111, 161-164, 355-361, 407-466.
20. McCauley J. A, Brittain H. G. Thermal methods of analysis, in: Brittain H. G. (Ed.), Physical Characterization of Pharmaceutical Solids. Drugs and Pharmaceutical Sciences, 1995; 70: 223-250
21. Mura P, Faucci M. T, Parrini P. L. Effect of grinding with microcrystalline cellulose and cyclodextrins on the ketoprofen physicochemical properties. Drug Dev. Ind. Pharm. 2001; 27 (2): 119-128.
22. Ghebremeskel A. N, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int. J. Pharm. 2007; 328: 119-129
23. Mihalic M, Hofman H, Kuftinec J, Krile B, Caplar V. and Kajfe F. Piroxicam, in Analytical Profiles of Drug Substances. (Florey Ed. K.), Academic Press, New York 1986; 15: 509-531.
24. Amidon G. E. Physical and mechanical property characterization of powders, in: Brittain H. G. (Ed.), Physical Characterization of Pharmaceutical Solids, Drugs and Pharmaceutical Sciences. Marcel Dekker Inc., New York, 1995; 70: 282-317.
25. Staniforth J, Powder flow, in: Aulton M. (Ed.). Pharmaceutics, the Science of Dosage Form Design, 2nd ed., Churchill Livingstone, Longman group, Edinburgh, 2002: pp. 197-210
26. Wells J. Pharmaceutical preformulation: the physicochemical properties of drug substances, in: Aulton M. (Ed.), Pharmaceutics the Science of Dosage Form Design, second ed., Churchill Livingstone, Longman group, Edinburgh 2002: 114-138.
27. Ansel H. C, Allen L. V, Popovich N. G. Pharmaceutical Dosage Forms and Drug Delivery Systems, seventh ed., Lippincott Williams and Wilkins, Philadelphia, 1999.
28. Shangraw R. F. Compressed tablets by direct compression, second ed., in: Lieberman H. A., Lachman L., Schwartz J. B. (Eds.). Pharmaceutical Dosage Forms Tablets, vol. 1, Marcel Dekker Inc., New York 1989: 195-220.
29. Fahmy R. H., Kassem M. A. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 2008; 69: 993-1003.
30. Javadzadeh Y, Siahi M. R., Asnaashari S., Nokhodchi A. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties. Acta Pharm 2007; 57: 99-109.